Please assess the completion status of the following clinical trial:

Trial Title: Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Depressive symptoms of mild intensity, as defined in the International Classification of Mental Disorders (ICD 10), codes F32.0 (mild depressive episode) and F33.0 (recurrent depressive disorder, current episode mild)~* SDS Index between 51 and 59 (this criterion was declared null and void on 21.02.02 in the 2nd Amendment)~* HAM-D21 scores between 10 and 17~* Between 18 and 70 years of age~* Duration of depression: not less than 4 weeks and not longer than 2 years~* Signed informed consent to take part in the clinical study after verbal and written information.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Verum (Type: EXPERIMENTAL): Neurapas balance, film-coated tablet
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).